#VisualAbstract: A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
1. An oral compound, SEP-363856 was shown to significantly reduce the total score of the Positive and Negative Symptom Scale ...
Tag: SEP-363856
SEP-363856 reduces symptom severity for acute exacerbation of schizophrenia
1. An oral compound, SEP-363856 was shown to significantly reduce the total score of the Positive and Negative Symptom Scale ...
2 Minute Medicine Rewind April 20, 2020
Association Between Visit-to-Visit Blood Pressure Variability in Early Adulthood and Myocardial Structure and Function in Later Life 1. Greater variability ...
